Guna is the most known pharmaceutical company in Italy in the field of low dose biological medicine and is the market leader with a revenue of over 60 Million Euros. The company was founded in 1983. Guna headquarters is located at Via Palmanova 71, Milan, Italy and the pharmaceutical plant for the production of low dose medicines, medical devices and cosmetics is located at Via Palmanova 69, Milan, Italy.
The Italian Health Ministry has authorized Guna for the production of pharmaceutical medicines since 1989. Since then, we have developed an innovative production department. The production plant has a surface of about 6.000 sq. mt. and is considered among the most modern pharmaceutical laboratories in the world.
We are certified according to the international norms GMP (Good Manufacturing Practice), ISO 9001:2008 and ISO 13485:2012
We employ about 300 people, working in the departments of production, logistic, administration, marketing and medical-scientific information.
Our products are distributed in over 30 Countries.
We also support several Associations to provide training for physicians and pharmacists.
We support numerous clinical and basic research initiatives conducted according to state-of-the-art scientific standards. Guna allocates a sizable part of its budget to research and development.
Due to the increase in demand from the US for innovative and modern health solutions, we expanded to North America.
GUNA Inc., the US subsidiary – located in Whitehall (PA) – opened its doors in 2006 to provide cutting edge solutions via the Guna Method and through our products.
We have more than 70 products FDA listed.
We are engaged not only in the production, but we are highly involved in research and development of Physiological Regulating Medicine.
Following firm ethical principles, we make it our own mission to respect human health. Our medicines have proven efficacy, are natural and do not have side effects nor contraindications.